The national utilization of nonoperative management for small renal masses over 10 years
Open Access
- 6 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 7 (6)
Abstract
Background: Management of small renal masses often involves a nonoperative approach, but there is a paucity of information about the use and associated predictors of such approaches. This study aimed to determine the trends in and predictors of use of nonoperative management of small renal masses. Methods: Using data from the National Cancer Database for localized small renal masses (N0/M0, cT1a) diagnosed between 2010 and 2020, we conducted a cross-sectional study. Nonoperative management was defined as expectant management (active surveillance or watchful waiting) or focal ablation. Adjusted odds ratios (AORs) were calculated using multivariable logistic regression models. Results: Of the 156 734 patients included, 10.5% underwent expectant management, and 13.9% underwent focal ablation. Later year of diagnosis was associated with a higher likelihood of nonoperative management. In 2020, the odds of receiving expectant management and focal ablation were 90% (AOR = 1.90, 95% confidence interval [CI] = 1.71 to 2.11) and 44% (AOR = 1.44, 95% CI = 1.31 to 1.57) higher, respectively, than in 2010. Black patients had increased odds of expectant management (AOR = 1.47, 95% CI = 1.39 to 1.55) but decreased odds of focal ablation (AOR = 0.93, 95% CI = 0.88 to 0.99). Conclusion: Over the decade, the use nonoperative management of small renal masses increased, with expectant management more frequently used than focal ablation among Black patients. Possible explanations include race-based differences in physicians' risk assessments and resource allocation. Adjusting for Black race in calculations for glomerular filtration rate could influence the differential uptake of these techniques through deflated glomerular filtration rate calculations. These findings highlight the need for research and policies to ensure equitable use of less invasive treatments in small renal masses.Keywords
This publication has 32 references indexed in Scilit:
- Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM RegistryJournal of Urology, 2018
- Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM RegistryEuropean Urology, 2015
- Renal Ablation UpdateSeminars in Interventional Radiology, 2014
- Active surveillance of small renal massesNature Reviews Urology, 2013
- Treatment of Localised Renal Cell CarcinomaEuropean Urology, 2011
- Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney CancerEuropean Urology, 2011
- Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or olderCancer, 2010
- Environmental and Socio-Economic Factors as Contributors to Racial Disparities in Diabetes PrevalenceJournal of General Internal Medicine, 2009
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Five‐year survival after surgical treatment for kidney cancerCancer, 2007